Oxidative Damage in Synovial Tissue is Associated with in Vivo Hypoxic Status in the Arthritic Joint
Overview
Authors
Affiliations
Objectives: To assess levels of oxidative DNA damage (8-oxo-7,8-dihydro-2'-deoxyguanine; 8-oxo-dG) and lipid peroxidation (4-hydroxy-2-nonenal; 4-HNE) in serum, synovial fluid and tissue of patients with inflammatory arthritis in relation to in vivo hypoxia levels, disease activity and angiogenic markers.
Methods: Oxygen levels in synovial tissue were assessed using an oxygen/temperature probe. Nuclear and cytoplasmic 8-oxo-dG and 4-HNE levels were assessed in synovial tissue from 23 patients by immunohistochemistry. 8-Oxo-dG and 4-HNE levels in serum and synovial fluid were determined using 8-oxo-dG and hexanoyl-Lys (HEL) adduct ELISAs, respectively. Serum vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang2) levels were also measured by ELISA.
Results: The median oxygen tension in synovial tissue was profoundly hypoxic at 19.35 mm Hg (2.5%). Nuclear 8-oxo-dG levels were significantly higher than nuclear 4-HNE levels in the lining and sublining layers (all p<0.001). In contrast, cytoplasmic 4-HNE levels were higher than cytoplasmic 8-oxo-dG levels in both cell layers (all p<0.001). Reduced in vivo oxygen tension correlated with high lipid peroxidation in synovial fluid (p=0.027; r=0.54) and tissue (p=0.004; r=0.58). Serum VEGF levels were positively correlated with cytoplasmic 4-HNE expression (p=0.05; r=0.43) and intensity (p=0.006; r=0.59) in the lining layer. Serum Ang2 levels were positively correlated with nuclear 4-HNE expression and intensity in both cell layers (all p < or = 0.05). DAS28-C-reactive protein was correlated with nuclear 4-HNE expression in the sublining layer (p=0.02; r=0.48) and DAS28-erythrocyte sedimentation rate was correlated with nuclear 4-HNE expression in both cell layers (p < or = 0.03).
Conclusions: Lipid peroxidation is associated with low oxygen tension in vivo, disease activity and angiogenic marker expression in inflammatory arthritis.
Giordo R, Posadino A, Maccioccu P, Capobianco G, Zinellu A, Erre G J Clin Med. 2024; 13(19).
PMID: 39407973 PMC: 11477295. DOI: 10.3390/jcm13195913.
Singh S, Prislovsky A, Ngwa D, Munkhsaikhan U, Abidi A, Brand D Front Immunol. 2024; 15:1385085.
PMID: 38650931 PMC: 11033386. DOI: 10.3389/fimmu.2024.1385085.
Luo T, Wu Y, Yin Q, Chen W, Zuo J J Inflamm Res. 2023; 16:1837-1852.
PMID: 37131409 PMC: 10149064. DOI: 10.2147/JIR.S398291.
Lu Y, Hao C, Yu S, Ma Z, Fu X, Qin M Arthritis Res Ther. 2022; 24(1):234.
PMID: 36253807 PMC: 9575222. DOI: 10.1186/s13075-022-02921-8.
Liu L, Luo P, Yang M, Wang J, Hou W, Xu P Front Mol Biosci. 2022; 9:1001212.
PMID: 36203877 PMC: 9532006. DOI: 10.3389/fmolb.2022.1001212.